• Molecular NameTerconazole
  • SynonymTriaconazole
  • Weight532.472
  • Drugbank_IDDB00251
  • ACS_NO67915-31-5
  • Show 3D model
  • LogP (experiment)5.361
  • LogP (predicted, AB/LogP v2.0)4.23
  • pkaN/A
  • LogD (pH=7, predicted)3.05
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-4.1
  • LogSw (predicted, AB/LogsW2.0)0.02
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds8
  • TPSA64.88
  • StatusFDA approved
  • AdministrationTopical
  • PharmacologyAn anti-fungal medication, primarily used to treat vaginal fungal infections.
  • Absorption_valueN/A
  • Absorption (description)Following intravaginal administration of terconazole in humans, absorption ranged from 5-8% in three hysterectomized subjects and 12-16% in two non-hysterectomized subjects with tubal ligations
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding94.9
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmHepatic
  • Half life6.9 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)LD50=1741 and 849 mg/kg (male and female rat)
  • LD50 (mouse)N/A